{"id":24473,"date":"2020-08-10T15:00:00","date_gmt":"2020-08-10T21:00:00","guid":{"rendered":"https:\/\/goldenti.com\/site\/?p=24473"},"modified":"2020-08-10T13:00:24","modified_gmt":"2020-08-10T19:00:24","slug":"curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19","status":"publish","type":"post","link":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/","title":{"rendered":"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19"},"content":{"rendered":"\n<p><strong>Reuters.-&nbsp;<\/strong>CureVac, uno de los principales candidatos de Alemania para desarrollar una vacuna contra la enfermedad Covid-19, dijo que&nbsp;<strong>pretende captar hasta 245 millones de d\u00f3lares en una oferta p\u00fablica de salida a bolsa<\/strong>&nbsp;en el mercado estadounidense Nasdaq.<\/p>\n\n\n\n<p>La empresa de biotecnolog\u00eda dijo este lunes que tiene previsto ofrecer un total de hasta 15.33 millones de nuevas acciones, a\u00f1adiendo que<strong>\u00a0las acciones probablemente tendr\u00e1n un precio de entre 14 y 16 d\u00f3lares cada una<\/strong>.<\/p>\n\n\n\n<p>Bank of America, Jefferies y Credit Suisse est\u00e1n actuando como \u201cbookrunners\u201d, con Berenberg y Kempen &amp; Co contribuyendo tambi\u00e9n en el proceso.<\/p>\n\n\n\n<p>Los<strong>\u00a0fondos recaudados financiar\u00e1n el desarrollo de una vacuna Covid-19 basada en ARNm<\/strong>, el aumento de las capacidades de fabricaci\u00f3n, el desarrollo de su f\u00e1rmaco oncol\u00f3gico y el desarrollo de una vacuna contra la rabia, entre otros proyectos, seg\u00fan el comunicado.<\/p>\n\n\n\n<p>El grupo, que est\u00e1 controlado por Dietmar Hopp, cofundador de la empresa de software SAP, y tambi\u00e9n est\u00e1 respaldado por la fundaci\u00f3n del cofundador de Microsoft, Bill Gates, anunci\u00f3 inicialmente sus planes de cotizar en bolsa el 24 de julio.<\/p>\n\n\n\n<p><strong>Hopp ha acordado comprar acciones por valor de 100 millones de euros\u00a0<\/strong>(117 millones de d\u00f3lares) en la oferta.<\/p>\n\n\n\n<p>Fuente: https:\/\/www.forbes.com.mx\/negocios-curevac-oferta-publica-crear-vacuna-contra-covid-19\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Reuters.-&nbsp;CureVac, uno de los principales candidatos de Alemania para desarrollar una vacuna contra la enfermedad Covid-19, [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":24474,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-24473","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categoria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19 -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19 -\" \/>\n<meta property=\"og:description\" content=\"Reuters.-&nbsp;CureVac, uno de los principales candidatos de Alemania para desarrollar una vacuna contra la enfermedad Covid-19, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-10T21:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19\",\"datePublished\":\"2020-08-10T21:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/\"},\"wordCount\":229,\"image\":{\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg\",\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/\",\"url\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/\",\"name\":\"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19 -\",\"isPartOf\":{\"@id\":\"https:\/\/goldenti.com\/site\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg\",\"datePublished\":\"2020-08-10T21:00:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#primaryimage\",\"url\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg\",\"contentUrl\":\"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg\",\"width\":640,\"height\":360},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/goldenti.com\/site\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/goldenti.com\/site\/#website\",\"url\":\"https:\/\/goldenti.com\/site\/\",\"name\":\"\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/goldenti.com\/site\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/goldenti.com\/site\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19 -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/","og_locale":"es_ES","og_type":"article","og_title":"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19 -","og_description":"Reuters.-&nbsp;CureVac, uno de los principales candidatos de Alemania para desarrollar una vacuna contra la enfermedad Covid-19, [&hellip;]","og_url":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/","article_published_time":"2020-08-10T21:00:00+00:00","og_image":[{"width":640,"height":360,"url":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#article","isPartOf":{"@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/"},"author":{"name":"","@id":""},"headline":"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19","datePublished":"2020-08-10T21:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/"},"wordCount":229,"image":{"@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg","inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/","url":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/","name":"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19 -","isPartOf":{"@id":"https:\/\/goldenti.com\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg","datePublished":"2020-08-10T21:00:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#primaryimage","url":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg","contentUrl":"https:\/\/goldenti.com\/site\/wp-content\/uploads\/2020\/08\/curevac_oferta_vacuna_desarrollo-640x360-1.jpg","width":640,"height":360},{"@type":"BreadcrumbList","@id":"https:\/\/goldenti.com\/site\/curevac-busca-245-mdd-en-oferta-publica-para-crear-vacuna-vs-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/goldenti.com\/site\/"},{"@type":"ListItem","position":2,"name":"CureVac busca 245 mdd en oferta p\u00fablica para crear vacuna vs. Covid-19"}]},{"@type":"WebSite","@id":"https:\/\/goldenti.com\/site\/#website","url":"https:\/\/goldenti.com\/site\/","name":"","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/goldenti.com\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"","url":"https:\/\/goldenti.com\/site\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/24473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/comments?post=24473"}],"version-history":[{"count":1,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/24473\/revisions"}],"predecessor-version":[{"id":24475,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/posts\/24473\/revisions\/24475"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/media\/24474"}],"wp:attachment":[{"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/media?parent=24473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/categories?post=24473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/goldenti.com\/site\/wp-json\/wp\/v2\/tags?post=24473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}